Roebuck Food Group PLC Issue of Consideration Shares (6332V)

TIDMRFG

RNS Number : 6332V

Roebuck Food Group PLC

04 December 2023

ROEBUCK FOOD GROUP PLC

("Roebuck" or "the Company", AIM: RFG)

Issue of Consideration Shares

4 December 2023

Roebuck Food Group plc (AIM: RFG), a group focused on growth and innovation within the food and agribusiness sectors (the "Company" or, "Roebuck") announced on 30 November, the shareholder approval for the completion of the acquisition of the entire share capital of Moorhead & McGavin Ltd, a food and food ingredient distribution business based in Motherwell, UK, ("the Acquisition"). The total consideration for the acquisition of the Moorhead & McGavin Limited was GBP2,225,000 with GBP2,075,000 in cash and remaining GBP150,000 via the issue of New Ordinary Shares in the Company to the Seller. The Company now confirms the issuance of the 1,071,428 new Ordinary Shares (the "Consideration Shares"), as outlined in the Circular published on 6 November 2023.

Application has been made to the London Stock Exchange for the Consideration Shares to be admitted to trading on AIM, with dealings expected to commence at 8 a.m. on or around 8 December 2023 ("Admission"). Following Admission, Roebuck will have a total of 49,660,320 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Roebuck Food Group under the FCA's Disclosure Guidance and Transparency Rules.

The directors of the Company accept responsibility for this announcement.

Enquiries:

Roebuck Food Group plc

   Aidan Hughes, Deputy Chairman                   Telephone: + 44 1293 862 498 

J & E Davy (Nomad)

   Anthony Farrell                                               Telephone: + 353 1 679 6363 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEMZMGZRDKGFZM

(END) Dow Jones Newswires

December 04, 2023 13:18 ET (18:18 GMT)